The introduction of Retatrutide ZPHC, at a dosage of 120mg, is sparking considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 receptor medication suggests to provide notable improvements in weight loss compared to current therapies. Initial clinical data have